PAG
BSX icon

Private Advisor Group’s Boston Scientific BSX Stock Holding History

Private Advisor Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,000
Closed -$1.06K – 2274
2023
Q3 		$1.06K Buy
+2,000
New +$105K ﹤0.01% 2257

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Private Advisor Group's BSX Position: Q2 2026 in Review

Private Advisor Group reduced its Boston Scientific (BSX) stake by 29% in Q2 2026, selling an estimated $627K and leaving 28,885 shares worth $1.23M. The position accounts for 0.01% of the portfolio, ranked #1257.

Private Advisor Group first reported a position in BSX in Q4 2013 and has held it in 49 quarters since. The position peaked at $14.7M in Q3 2021. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Private Advisor Group held 28,885 shares of Boston Scientific worth $1.23M as of Q2 2026.
  • Private Advisor Group sold 11,555 Boston Scientific shares in Q2 2026, an estimated $627K.
  • Boston Scientific made up 0.01% of Private Advisor Group's portfolio in Q2 2026, its #1257 holding.
  • Private Advisor Group first reported a position in Boston Scientific in Q4 2013 and has held it in 49 quarters since.
  • Private Advisor Group's Boston Scientific position peaked at $14.7M in Q3 2021.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.